PHARMOSA BIOPHARM INC has a total of 28 patent applications. Its first patent ever was published in 2014. It filed its patents most often in Taiwan, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals are BIOTEC BIOLOGICA IND FARMACEUTICA LTDA E P P, LIOMONT S A DE C V LAB and THE BOT OF THE LELAND STANFORD JUNIOR UNIV.
# | Country | Total Patents | |
---|---|---|---|
#1 | Taiwan | 4 | |
#2 | United States | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 3 | |
#5 | Canada | 3 | |
#6 | Brazil | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Singapore | 2 | |
#10 | China | 1 | |
#11 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kan Pei | 24 |
#2 | Lin Yi Fong | 21 |
#3 | Chen Ko Chieh | 15 |
#4 | Chen Kochieh | 7 |
#5 | Lin Yi-Fong | 3 |
#6 | Chen Ko-Chieh | 2 |
#7 | Yi Fong Lin | 2 |
#8 | Pei Kan | 2 |
#9 | Su Yu De | 1 |
#10 | Ko Chieh Chen | 1 |
Publication | Filing date | Title |
---|---|---|
US2020360320A1 | Pharmaceutical composition of a weak acid drug and methods of administration | |
US2020085741A1 | Pharmaceutical composition for controlled release of weak acid drugs and uses thereof | |
AU2019266171A1 | Pharmaceutical composition for controlled release of treprostinil | |
EP3658134A1 | Liposome compositions comprising weak acid drugs and uses thereof | |
TW201600121A | High drug load pharmaceutical compositions with controllable release rate and production methods thereof |